• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMU
Click for more information
4.26% 4.5¢

IMUGENE LIMITED - Announcements

Market Cap $386.7M  ! watchlist Created with Sketch. Add to my watchlist

Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing... Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its platform technology seeks to harness and promote the body’s immune system against cancerous tumors. Its product pipeline includes an off-the-shelf (allogeneic) cell therapy CAR T drug Azer-Cel (azercabtagene zapreleucel) which targets CD19 to attack blood cancer. Its pipeline includes an Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard of care drugs and immunotherapies. Its lead candidate is a chimeric vaccinia (pox) virus known as CF33, which is a combination of genomic sequences from multiple vaccinia virus strains to generate a new, safer and more potent virus. Its Chimeric antigen receptor (CAR)-engineered T cells (CAR T) are T cells redirected against tumors through engineered expression of CARs. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
IMUResults of Meeting17/07/12
IMUNotice of General Meeting/Proxy Form15/06/12
IMUInvestor Presentation10/05/12
CGP +Agreement reached with Imugene for sale of Linguet IPPRICE SENSITIVE01/05/12
CGP +Acquisition of Drug Delivery Platform and Share PlacementPRICE SENSITIVE01/05/12
IMUTrading HaltPRICE SENSITIVE30/04/12
IMUQuarterly Report and Appendix 4CPRICE SENSITIVE30/04/12
IMUHalf Yearly Report and AccountsPRICE SENSITIVE29/02/12
IMUQuarterly Report and Appendix 4CPRICE SENSITIVE24/01/12
IMUTechnology UpdatePRICE SENSITIVE11/01/12
IMUResults of Meeting30/11/11
IMUTechnology UpdatePRICE SENSITIVE29/11/11
IMUQuarterly Report and Appendix 4CPRICE SENSITIVE31/10/11
IMUNotice of Annual General Meeting/Proxy Form26/10/11
IMUAnnual Report to shareholders26/10/11
IMUGlobal License AgreementPRICE SENSITIVE02/09/11
IMUTrading haltPRICE SENSITIVE01/09/11
IMUAppendix 4E and 2011 Financial ReportPRICE SENSITIVE29/08/11
IMUQuarterly Report and Appendix 4CPRICE SENSITIVE29/07/11
IMUQuarterly Report and Appendix 4CPRICE SENSITIVE29/04/11
IMURevised 4D28/02/11
IMUHalf Yearly Report and AccountsPRICE SENSITIVE25/02/11
IMUQuarterly Report and Appendix 4CPRICE SENSITIVE31/01/11
IMUPolicy for Trading in Company Securities24/12/10
IMUResults of Meeting26/11/10
IMUAGM Presentation26/11/10
IMUReceipt of Initial Fees From LicenseePRICE SENSITIVE12/11/10
IMUQuarterly Report and Appendix 4CPRICE SENSITIVE29/10/10
IMUAnnual Report to shareholders26/10/10
IMUNotice of Annual General Meeting/Proxy Form26/10/10
IMUImugene Signs Global AgreementPRICE SENSITIVE13/10/10
IMUFull Year Statutory Accounts and Update30/09/10
IMUSecond Successful PRRS VaccineTrialPRICE SENSITIVE16/09/10
IMUPreliminary Final ReportPRICE SENSITIVE31/08/10
IMUQuarterly Report and Appendix 4CPRICE SENSITIVE30/07/10
IMUShareholder Update Commercial NegotiationsPRICE SENSITIVE02/07/10
IMUQuarterly Update and Appendix 4CPRICE SENSITIVE30/04/10
IMUInvestor UpdatePRICE SENSITIVE07/04/10
IMUHalf Yearly Report and AccountsPRICE SENSITIVE25/02/10
IMUQuarterly Update and Appendix 4CPRICE SENSITIVE29/01/10
IMUStrategic Alliance UpdatePRICE SENSITIVE11/01/10
IMUExpiry of Unlisted Options05/01/10
IMUChange of Director's Interest Notice x 205/01/10
IMUAGM Presentation27/11/09
IMUResults of Meeting27/11/09
IMUStrategic Alliance Update24/11/09
IMUQuarterly Report and Appendix 4CPRICE SENSITIVE28/10/09
IMUNotice of Annual General Meeting/Proxy Form27/10/09
IMUAnnual Report to shareholders27/10/09
IMUAppendix 4E and 2009 Financial ReportPRICE SENSITIVE28/08/09
IMUResponse to ASX QueryPRICE SENSITIVE19/08/09
IMUChange of Director's Interest Notices19/08/09
IMUChange of Director's Interest Notice14/08/09
IMUAppendix 4C - quarterlyPRICE SENSITIVE31/07/09
IMUSwine Influenza UpdatePRICE SENSITIVE27/07/09
IMUChange of Director's Interest Notice07/05/09
IMUAppendix 4C - quarterlyPRICE SENSITIVE30/04/09
IMUSwine Influenza VaccinesPRICE SENSITIVE28/04/09
IMUHalf Yearly Report and AccountsPRICE SENSITIVE26/02/09
IMUQuarterly Report and Apprndix 4CPRICE SENSITIVE30/01/09
IMUImugene and Merial establish a Strategic AlliancePRICE SENSITIVE31/12/08
IMUTrading Halt - AmendedPRICE SENSITIVE30/12/08
IMUTrading HaltPRICE SENSITIVE30/12/08
IMUCAP Correction: Incorrect ASX Code - should be IGG24/12/08
IMU +Change in substantial holding from UXC24/12/08
IMUResults of Annual General Meeting28/11/08
IMUAGM Presentation28/11/08
IMUResults of Meeting
17/07/12
IMUNotice of General Meeting/Proxy Form
15/06/12
IMUInvestor Presentation
10/05/12
CGP +Agreement reached with Imugene for sale of Linguet IP
01/05/12PRICE SENSITIVE
CGP +Acquisition of Drug Delivery Platform and Share Placement
01/05/12PRICE SENSITIVE
IMUTrading Halt
30/04/12PRICE SENSITIVE
IMUQuarterly Report and Appendix 4C
30/04/12PRICE SENSITIVE
IMUHalf Yearly Report and Accounts
29/02/12PRICE SENSITIVE
IMUQuarterly Report and Appendix 4C
24/01/12PRICE SENSITIVE
IMUTechnology Update
11/01/12PRICE SENSITIVE
IMUResults of Meeting
30/11/11
IMUTechnology Update
29/11/11PRICE SENSITIVE
IMUQuarterly Report and Appendix 4C
31/10/11PRICE SENSITIVE
IMUNotice of Annual General Meeting/Proxy Form
26/10/11
IMUAnnual Report to shareholders
26/10/11
IMUGlobal License Agreement
02/09/11PRICE SENSITIVE
IMUTrading halt
01/09/11PRICE SENSITIVE
IMUAppendix 4E and 2011 Financial Report
29/08/11PRICE SENSITIVE
IMUQuarterly Report and Appendix 4C
29/07/11PRICE SENSITIVE
IMUQuarterly Report and Appendix 4C
29/04/11PRICE SENSITIVE
IMURevised 4D
28/02/11
IMUHalf Yearly Report and Accounts
25/02/11PRICE SENSITIVE
IMUQuarterly Report and Appendix 4C
31/01/11PRICE SENSITIVE
IMUPolicy for Trading in Company Securities
24/12/10
IMUResults of Meeting
26/11/10
IMUAGM Presentation
26/11/10
IMUReceipt of Initial Fees From Licensee
12/11/10PRICE SENSITIVE
IMUQuarterly Report and Appendix 4C
29/10/10PRICE SENSITIVE
IMUAnnual Report to shareholders
26/10/10
IMUNotice of Annual General Meeting/Proxy Form
26/10/10
IMUImugene Signs Global Agreement
13/10/10PRICE SENSITIVE
IMUFull Year Statutory Accounts and Update
30/09/10
IMUSecond Successful PRRS VaccineTrial
16/09/10PRICE SENSITIVE
IMUPreliminary Final Report
31/08/10PRICE SENSITIVE
IMUQuarterly Report and Appendix 4C
30/07/10PRICE SENSITIVE
IMUShareholder Update Commercial Negotiations
02/07/10PRICE SENSITIVE
IMUQuarterly Update and Appendix 4C
30/04/10PRICE SENSITIVE
IMUInvestor Update
07/04/10PRICE SENSITIVE
IMUHalf Yearly Report and Accounts
25/02/10PRICE SENSITIVE
IMUQuarterly Update and Appendix 4C
29/01/10PRICE SENSITIVE
IMUStrategic Alliance Update
11/01/10PRICE SENSITIVE
IMUExpiry of Unlisted Options
05/01/10
IMUChange of Director's Interest Notice x 2
05/01/10
IMUAGM Presentation
27/11/09
IMUResults of Meeting
27/11/09
IMUStrategic Alliance Update
24/11/09
IMUQuarterly Report and Appendix 4C
28/10/09PRICE SENSITIVE
IMUNotice of Annual General Meeting/Proxy Form
27/10/09
IMUAnnual Report to shareholders
27/10/09
IMUAppendix 4E and 2009 Financial Report
28/08/09PRICE SENSITIVE
IMUResponse to ASX Query
19/08/09PRICE SENSITIVE
IMUChange of Director's Interest Notices
19/08/09
IMUChange of Director's Interest Notice
14/08/09
IMUAppendix 4C - quarterly
31/07/09PRICE SENSITIVE
IMUSwine Influenza Update
27/07/09PRICE SENSITIVE
IMUChange of Director's Interest Notice
07/05/09
IMUAppendix 4C - quarterly
30/04/09PRICE SENSITIVE
IMUSwine Influenza Vaccines
28/04/09PRICE SENSITIVE
IMUHalf Yearly Report and Accounts
26/02/09PRICE SENSITIVE
IMUQuarterly Report and Apprndix 4C
30/01/09PRICE SENSITIVE
IMUImugene and Merial establish a Strategic Alliance
31/12/08PRICE SENSITIVE
IMUTrading Halt - Amended
30/12/08PRICE SENSITIVE
IMUTrading Halt
30/12/08PRICE SENSITIVE
IMUCAP Correction: Incorrect ASX Code - should be IGG
24/12/08
IMU +Change in substantial holding from UXC
24/12/08
IMUResults of Annual General Meeting
28/11/08
IMUAGM Presentation
28/11/08
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
4.5¢ 		Change
-0.002(4.26%) 		Mkt cap ! $386.7M
Open High Low Value Volume
4.7¢ 4.8¢ 4.4¢ $890.8K 19.42M

Buyers (Bids)

No. Vol. Price($)
2 176601 4.5¢
 

Sellers (Offers)

Price($) Vol. No.
4.6¢ 969572 8
View Market Depth
Last trade - 16.10pm 06/11/2024 (20 minute delay) ?
Last
4.5¢ 		  Change
-0.002 ( 2.81 %)
Open High Low Volume
4.8¢ 4.8¢ 4.5¢ 9435451
Last updated 15.59pm 06/11/2024 ?
IMU (ASX) Chart

Top Stories

Lord picks up high-grade copper play in Western Australia, with past intercepts of up to 6.62%

Lor Resources Ltd has entered into a binding earn-in agreement with Blackrock Resources Pty Ltd to take on up to 80% of the Ilgarari project
The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint Let’s get straight to the point: of all the smallcaps in the Telecommunications index, The Market Ltd could be one of the most overlooked.
Nanocap Si6 Metals to kick off drilling at Monument gold project WA, chasing past hits Nanocap Si6 Metals (ASX:SI6) is on the cusp of kicking off drilling at its Monument project in WA, sniffing after historical gold hit targets.
Bitcoin jumps 8% to beat record on Trump vote optimism Bitcoin has been a big winner on financial markets today, tracking Donald Trump's election highs with an 8% rise and beating a previous record
Palladium's the newest geopolitical hot commodity. But ASX exposure is limited On October 24, the USA reportedly approached its G7 counterparts and proposed a ban on Russian titanium, and, palladium.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.